Debt-Free Public Shell (QB) for Sale - SEC Reporting Ready

This listing presents a unique opportunity to acquire a debt-free public shell company (QB) that is fully SEC reporting and ready for immediate sale. Positioned within the biotech industry, this company is structured for an RTO (Reverse Takeover) and is easily uplisted to Nasdaq. Key features include a substantial number of common shares outstanding, a significant portion of free trading shares, and DTC eligibility. The company is in good standing with current state and federal tax filings, and all regulatory filings are up-to-date. This offering is ideal for entities seeking a compliant public vehicle for strategic transactions.